 | • レポートコード：MRC2-11QY03349 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、113ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は血液希釈剤のグローバル市場について調査・分析したレポートです。種類別（抗凝固剤、抗血小板薬）市場規模、用途別（注射可抗凝血剤、経口抗凝血剤）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別血液希釈剤の競争状況、市場シェア ・世界の血液希釈剤市場：種類別市場規模 2015年-2020年（抗凝固剤、抗血小板薬） ・世界の血液希釈剤市場：種類別市場規模予測 2021年-2026年（抗凝固剤、抗血小板薬） ・世界の血液希釈剤市場：用途別市場規模 2015年-2020年（注射可抗凝血剤、経口抗凝血剤） ・世界の血液希釈剤市場：用途別市場規模予測 2021年-2026年（注射可抗凝血剤、経口抗凝血剤） ・北米の血液希釈剤市場分析：米国、カナダ ・ヨーロッパの血液希釈剤市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの血液希釈剤市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の血液希釈剤市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの血液希釈剤市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Bayer、Pfizer、Merck、Sanofi、Abbott、Johnson and Johnson、Baxter、AstraZeneca ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Blood-thinning Drugs Market
The global Blood-thinning Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Blood-thinning Drugs Scope and Market Size
Blood-thinning Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Blood-thinning Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Blood-thinning Drugs market is segmented into
Anticoagulants
Antiplatelet Drugs
Segment by Application, the Blood-thinning Drugs market is segmented into
Injectable Blood Thinners
Oral Blood Thinners
Regional and Country-level Analysis
The Blood-thinning Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Blood-thinning Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Blood-thinning Drugs Market Share Analysis
Blood-thinning Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Blood-thinning Drugs business, the date to enter into the Blood-thinning Drugs market, Blood-thinning Drugs product introduction, recent developments, etc.
The major vendors covered:
Bayer
Pfizer
Merck
Sanofi
Abbott
Johnson and Johnson
Baxter
AstraZeneca
1 Study Coverage
1.1 Blood-thinning Drugs Product Introduction
1.2 Market Segments
1.3 Key Blood-thinning Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Blood-thinning Drugs Market Size Growth Rate by Type
1.4.2 Anticoagulants
1.4.3 Antiplatelet Drugs
1.5 Market by Application
1.5.1 Global Blood-thinning Drugs Market Size Growth Rate by Application
1.5.2 Injectable Blood Thinners
1.5.3 Oral Blood Thinners
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Blood-thinning Drugs Market Size, Estimates and Forecasts
2.1.1 Global Blood-thinning Drugs Revenue 2015-2026
2.1.2 Global Blood-thinning Drugs Sales 2015-2026
2.2 Global Blood-thinning Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Blood-thinning Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Blood-thinning Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Blood-thinning Drugs Competitor Landscape by Players
3.1 Blood-thinning Drugs Sales by Manufacturers
3.1.1 Blood-thinning Drugs Sales by Manufacturers (2015-2020)
3.1.2 Blood-thinning Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Blood-thinning Drugs Revenue by Manufacturers
3.2.1 Blood-thinning Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Blood-thinning Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Blood-thinning Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Blood-thinning Drugs Revenue in 2019
3.2.5 Global Blood-thinning Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Blood-thinning Drugs Price by Manufacturers
3.4 Blood-thinning Drugs Manufacturing Base Distribution, Product Types
3.4.1 Blood-thinning Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Blood-thinning Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Blood-thinning Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Blood-thinning Drugs Market Size by Type (2015-2020)
4.1.1 Global Blood-thinning Drugs Sales by Type (2015-2020)
4.1.2 Global Blood-thinning Drugs Revenue by Type (2015-2020)
4.1.3 Blood-thinning Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Blood-thinning Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Blood-thinning Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Blood-thinning Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Blood-thinning Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Blood-thinning Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Blood-thinning Drugs Market Size by Application (2015-2020)
5.1.1 Global Blood-thinning Drugs Sales by Application (2015-2020)
5.1.2 Global Blood-thinning Drugs Revenue by Application (2015-2020)
5.1.3 Blood-thinning Drugs Price by Application (2015-2020)
5.2 Blood-thinning Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Blood-thinning Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Blood-thinning Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Blood-thinning Drugs Price Forecast by Application (2021-2026)
6 North America
6.1 North America Blood-thinning Drugs by Country
6.1.1 North America Blood-thinning Drugs Sales by Country
6.1.2 North America Blood-thinning Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Blood-thinning Drugs Market Facts & Figures by Type
6.3 North America Blood-thinning Drugs Market Facts & Figures by Application
7 Europe
7.1 Europe Blood-thinning Drugs by Country
7.1.1 Europe Blood-thinning Drugs Sales by Country
7.1.2 Europe Blood-thinning Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Blood-thinning Drugs Market Facts & Figures by Type
7.3 Europe Blood-thinning Drugs Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Blood-thinning Drugs by Region
8.1.1 Asia Pacific Blood-thinning Drugs Sales by Region
8.1.2 Asia Pacific Blood-thinning Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Blood-thinning Drugs Market Facts & Figures by Type
8.3 Asia Pacific Blood-thinning Drugs Market Facts & Figures by Application
9 Latin America
9.1 Latin America Blood-thinning Drugs by Country
9.1.1 Latin America Blood-thinning Drugs Sales by Country
9.1.2 Latin America Blood-thinning Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Blood-thinning Drugs Market Facts & Figures by Type
9.3 Central & South America Blood-thinning Drugs Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Blood-thinning Drugs by Country
10.1.1 Middle East and Africa Blood-thinning Drugs Sales by Country
10.1.2 Middle East and Africa Blood-thinning Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Blood-thinning Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Blood-thinning Drugs Market Facts & Figures by Application
11 Company Profiles
11.1 Bayer
11.1.1 Bayer Corporation Information
11.1.2 Bayer Description and Business Overview
11.1.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Bayer Blood-thinning Drugs Products Offered
11.1.5 Bayer Related Developments
11.2 Pfizer
11.2.1 Pfizer Corporation Information
11.2.2 Pfizer Description and Business Overview
11.2.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Pfizer Blood-thinning Drugs Products Offered
11.2.5 Pfizer Related Developments
11.3 Merck
11.3.1 Merck Corporation Information
11.3.2 Merck Description and Business Overview
11.3.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Merck Blood-thinning Drugs Products Offered
11.3.5 Merck Related Developments
11.4 Sanofi
11.4.1 Sanofi Corporation Information
11.4.2 Sanofi Description and Business Overview
11.4.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Sanofi Blood-thinning Drugs Products Offered
11.4.5 Sanofi Related Developments
11.5 Abbott
11.5.1 Abbott Corporation Information
11.5.2 Abbott Description and Business Overview
11.5.3 Abbott Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Abbott Blood-thinning Drugs Products Offered
11.5.5 Abbott Related Developments
11.6 Johnson and Johnson
11.6.1 Johnson and Johnson Corporation Information
11.6.2 Johnson and Johnson Description and Business Overview
11.6.3 Johnson and Johnson Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Johnson and Johnson Blood-thinning Drugs Products Offered
11.6.5 Johnson and Johnson Related Developments
11.7 Baxter
11.7.1 Baxter Corporation Information
11.7.2 Baxter Description and Business Overview
11.7.3 Baxter Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Baxter Blood-thinning Drugs Products Offered
11.7.5 Baxter Related Developments
11.8 AstraZeneca
11.8.1 AstraZeneca Corporation Information
11.8.2 AstraZeneca Description and Business Overview
11.8.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
11.8.4 AstraZeneca Blood-thinning Drugs Products Offered
11.8.5 AstraZeneca Related Developments
11.1 Bayer
11.1.1 Bayer Corporation Information
11.1.2 Bayer Description and Business Overview
11.1.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Bayer Blood-thinning Drugs Products Offered
11.1.5 Bayer Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Blood-thinning Drugs Market Estimates and Projections by Region
12.1.1 Global Blood-thinning Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Blood-thinning Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Blood-thinning Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Blood-thinning Drugs Sales Forecast (2021-2026)
12.2.2 North America: Blood-thinning Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Blood-thinning Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Blood-thinning Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Blood-thinning Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Blood-thinning Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Blood-thinning Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Blood-thinning Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Blood-thinning Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Blood-thinning Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Blood-thinning Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Blood-thinning Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Blood-thinning Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Blood-thinning Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Blood-thinning Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Blood-thinning Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Blood-thinning Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Blood-thinning Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Blood-thinning Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Blood-thinning Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Blood-thinning Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Blood-thinning Drugs Market Segments
Table 2. Ranking of Global Top Blood-thinning Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Blood-thinning Drugs Market Size Growth Rate by Type 2020-2026 (Units) & (US$ Million)
Table 4. Major Manufacturers of Anticoagulants
Table 5. Major Manufacturers of Antiplatelet Drugs
Table 6. Global Blood-thinning Drugs Market Size Growth Rate by Application 2020-2026 (Units)
Table 7. Global Blood-thinning Drugs Market Size by Region (Units) & (US$ Million): 2020 VS 2026
Table 8. Global Blood-thinning Drugs Sales by Regions 2015-2020 (Units)
Table 9. Global Blood-thinning Drugs Sales Market Share by Regions (2015-2020)
Table 10. Global Blood-thinning Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Blood-thinning Drugs Sales by Manufacturers (2015-2020) (Units)
Table 12. Global Blood-thinning Drugs Sales Share by Manufacturers (2015-2020)
Table 13. Global Blood-thinning Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Blood-thinning Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Blood-thinning Drugs as of 2019)
Table 15. Blood-thinning Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Blood-thinning Drugs Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Blood-thinning Drugs Price (2015-2020) (K USD/Unit)
Table 18. Blood-thinning Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Blood-thinning Drugs Product Type
Table 20. Date of International Manufacturers Enter into Blood-thinning Drugs Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Blood-thinning Drugs Sales by Type (2015-2020) (Units)
Table 23. Global Blood-thinning Drugs Sales Share by Type (2015-2020)
Table 24. Global Blood-thinning Drugs Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Blood-thinning Drugs Revenue Share by Type (2015-2020)
Table 26. Blood-thinning Drugs Average Selling Price (ASP) by Type 2015-2020 (K USD/Unit)
Table 27. Global Blood-thinning Drugs Sales by Application (2015-2020) (Units)
Table 28. Global Blood-thinning Drugs Sales Share by Application (2015-2020)
Table 29. North America Blood-thinning Drugs Sales by Country (2015-2020) (Units)
Table 30. North America Blood-thinning Drugs Sales Market Share by Country (2015-2020)
Table 31. North America Blood-thinning Drugs Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Blood-thinning Drugs Revenue Market Share by Country (2015-2020)
Table 33. North America Blood-thinning Drugs Sales by Type (2015-2020) (Units)
Table 34. North America Blood-thinning Drugs Sales Market Share by Type (2015-2020)
Table 35. North America Blood-thinning Drugs Sales by Application (2015-2020) (Units)
Table 36. North America Blood-thinning Drugs Sales Market Share by Application (2015-2020)
Table 37. Europe Blood-thinning Drugs Sales by Country (2015-2020) (Units)
Table 38. Europe Blood-thinning Drugs Sales Market Share by Country (2015-2020)
Table 39. Europe Blood-thinning Drugs Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Blood-thinning Drugs Revenue Market Share by Country (2015-2020)
Table 41. Europe Blood-thinning Drugs Sales by Type (2015-2020) (Units)
Table 42. Europe Blood-thinning Drugs Sales Market Share by Type (2015-2020)
Table 43. Europe Blood-thinning Drugs Sales by Application (2015-2020) (Units)
Table 44. Europe Blood-thinning Drugs Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Blood-thinning Drugs Sales by Region (2015-2020) (Units)
Table 46. Asia Pacific Blood-thinning Drugs Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Blood-thinning Drugs Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Blood-thinning Drugs Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Blood-thinning Drugs Sales by Type (2015-2020) (Units)
Table 50. Asia Pacific Blood-thinning Drugs Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Blood-thinning Drugs Sales by Application (2015-2020) (Units)
Table 52. Asia Pacific Blood-thinning Drugs Sales Market Share by Application (2015-2020)
Table 53. Latin America Blood-thinning Drugs Sales by Country (2015-2020) (Units)
Table 54. Latin America Blood-thinning Drugs Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Blood-thinning Drugs Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Blood-thinning Drugs Revenue Market Share by Country (2015-2020)
Table 57. Latin America Blood-thinning Drugs Sales by Type (2015-2020) (Units)
Table 58. Latin America Blood-thinning Drugs Sales Market Share by Type (2015-2020)
Table 59. Latin America Blood-thinning Drugs Sales by Application (2015-2020) (Units)
Table 60. Latin America Blood-thinning Drugs Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Blood-thinning Drugs Sales by Country (2015-2020) (Units)
Table 62. Middle East and Africa Blood-thinning Drugs Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Blood-thinning Drugs Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Blood-thinning Drugs Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Blood-thinning Drugs Sales by Type (2015-2020) (Units)
Table 66. Middle East and Africa Blood-thinning Drugs Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Blood-thinning Drugs Sales by Application (2015-2020) (Units)
Table 68. Middle East and Africa Blood-thinning Drugs Sales Market Share by Application (2015-2020)
Table 69. Bayer Corporation Information
Table 70. Bayer Description and Major Businesses
Table 71. Bayer Blood-thinning Drugs Production (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2015-2020)
Table 72. Bayer Product
Table 73. Bayer Recent Development
Table 74. Pfizer Corporation Information
Table 75. Pfizer Description and Major Businesses
Table 76. Pfizer Blood-thinning Drugs Production (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2015-2020)
Table 77. Pfizer Product
Table 78. Pfizer Recent Development
Table 79. Merck Corporation Information
Table 80. Merck Description and Major Businesses
Table 81. Merck Blood-thinning Drugs Production (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2015-2020)
Table 82. Merck Product
Table 83. Merck Recent Development
Table 84. Sanofi Corporation Information
Table 85. Sanofi Description and Major Businesses
Table 86. Sanofi Blood-thinning Drugs Production (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2015-2020)
Table 87. Sanofi Product
Table 88. Sanofi Recent Development
Table 89. Abbott Corporation Information
Table 90. Abbott Description and Major Businesses
Table 91. Abbott Blood-thinning Drugs Production (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2015-2020)
Table 92. Abbott Product
Table 93. Abbott Recent Development
Table 94. Johnson and Johnson Corporation Information
Table 95. Johnson and Johnson Description and Major Businesses
Table 96. Johnson and Johnson Blood-thinning Drugs Production (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2015-2020)
Table 97. Johnson and Johnson Product
Table 98. Johnson and Johnson Recent Development
Table 99. Baxter Corporation Information
Table 100. Baxter Description and Major Businesses
Table 101. Baxter Blood-thinning Drugs Production (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2015-2020)
Table 102. Baxter Product
Table 103. Baxter Recent Development
Table 104. AstraZeneca Corporation Information
Table 105. AstraZeneca Description and Major Businesses
Table 106. AstraZeneca Blood-thinning Drugs Production (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2015-2020)
Table 107. AstraZeneca Product
Table 108. AstraZeneca Recent Development
Table 109. Global Blood-thinning Drugs Sales Forecast by Regions (2021-2026) (Units)
Table 110. Global Blood-thinning Drugs Sales Market Share Forecast by Regions (2021-2026)
Table 111. Global Blood-thinning Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 112. Global Blood-thinning Drugs Revenue Market Share Forecast by Regions (2021-2026)
Table 113. North America: Blood-thinning Drugs Sales Forecast by Country (2021-2026) (Units)
Table 114. North America: Blood-thinning Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 115. Europe: Blood-thinning Drugs Sales Forecast by Country (2021-2026) (Units)
Table 116. Europe: Blood-thinning Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 117. Asia Pacific: Blood-thinning Drugs Sales Forecast by Region (2021-2026) (Units)
Table 118. Asia Pacific: Blood-thinning Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 119. Latin America: Blood-thinning Drugs Sales Forecast by Country (2021-2026) (Units)
Table 120. Latin America: Blood-thinning Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 121. Middle East and Africa: Blood-thinning Drugs Sales Forecast by Country (2021-2026) (Units)
Table 122. Middle East and Africa: Blood-thinning Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 123. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 124. Key Challenges
Table 125. Market Risks
Table 126. Main Points Interviewed from Key Blood-thinning Drugs Players
Table 127. Blood-thinning Drugs Customers List
Table 128. Blood-thinning Drugs Distributors List
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources
List of Figures
Figure 1. Blood-thinning Drugs Product Picture
Figure 2. Global Blood-thinning Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Anticoagulants Product Picture
Figure 4. Antiplatelet Drugs Product Picture
Figure 5. Global Blood-thinning Drugs Sales Market Share by Application in 2020 & 2026
Figure 6. Injectable Blood Thinners
Figure 7. Oral Blood Thinners
Figure 8. Blood-thinning Drugs Report Years Considered
Figure 9. Global Blood-thinning Drugs Market Size 2015-2026 (US$ Million)
Figure 10. Global Blood-thinning Drugs Sales 2015-2026 (Units)
Figure 11. Global Blood-thinning Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 12. Global Blood-thinning Drugs Sales Market Share by Region (2015-2020)
Figure 13. Global Blood-thinning Drugs Sales Market Share by Region in 2019
Figure 14. Global Blood-thinning Drugs Revenue Market Share by Region (2015-2020)
Figure 15. Global Blood-thinning Drugs Revenue Market Share by Region in 2019
Figure 16. Global Blood-thinning Drugs Sales Share by Manufacturer in 2019
Figure 17. The Top 10 and 5 Players Market Share by Blood-thinning Drugs Revenue in 2019
Figure 18. Blood-thinning Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global Blood-thinning Drugs Sales Market Share by Type (2015-2020)
Figure 20. Global Blood-thinning Drugs Sales Market Share by Type in 2019
Figure 21. Global Blood-thinning Drugs Revenue Market Share by Type (2015-2020)
Figure 22. Global Blood-thinning Drugs Revenue Market Share by Type in 2019
Figure 23. Global Blood-thinning Drugs Market Share by Price Range (2015-2020)
Figure 24. Global Blood-thinning Drugs Sales Market Share by Application (2015-2020)
Figure 25. Global Blood-thinning Drugs Sales Market Share by Application in 2019
Figure 26. Global Blood-thinning Drugs Revenue Market Share by Application (2015-2020)
Figure 27. Global Blood-thinning Drugs Revenue Market Share by Application in 2019
Figure 28. North America Blood-thinning Drugs Sales Growth Rate 2015-2020 (Units)
Figure 29. North America Blood-thinning Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 30. North America Blood-thinning Drugs Sales Market Share by Country in 2019
Figure 31. North America Blood-thinning Drugs Revenue Market Share by Country in 2019
Figure 32. U.S. Blood-thinning Drugs Sales Growth Rate (2015-2020) (Units)
Figure 33. U.S. Blood-thinning Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. Canada Blood-thinning Drugs Sales Growth Rate (2015-2020) (Units)
Figure 35. Canada Blood-thinning Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. North America Blood-thinning Drugs Market Share by Type in 2019
Figure 37. North America Blood-thinning Drugs Market Share by Application in 2019
Figure 38. Europe Blood-thinning Drugs Sales Growth Rate 2015-2020 (Units)
Figure 39. Europe Blood-thinning Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 40. Europe Blood-thinning Drugs Sales Market Share by Country in 2019
Figure 41. Europe Blood-thinning Drugs Revenue Market Share by Country in 2019
Figure 42. Germany Blood-thinning Drugs Sales Growth Rate (2015-2020) (Units)
Figure 43. Germany Blood-thinning Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. France Blood-thinning Drugs Sales Growth Rate (2015-2020) (Units)
Figure 45. France Blood-thinning Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. U.K. Blood-thinning Drugs Sales Growth Rate (2015-2020) (Units)
Figure 47. U.K. Blood-thinning Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Italy Blood-thinning Drugs Sales Growth Rate (2015-2020) (Units)
Figure 49. Italy Blood-thinning Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Russia Blood-thinning Drugs Sales Growth Rate (2015-2020) (Units)
Figure 51. Russia Blood-thinning Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Europe Blood-thinning Drugs Market Share by Type in 2019
Figure 53. Europe Blood-thinning Drugs Market Share by Application in 2019
Figure 54. Asia Pacific Blood-thinning Drugs Sales Growth Rate 2015-2020 (Units)
Figure 55. Asia Pacific Blood-thinning Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 56. Asia Pacific Blood-thinning Drugs Sales Market Share by Region in 2019
Figure 57. Asia Pacific Blood-thinning Drugs Revenue Market Share by Region in 2019
Figure 58. China Blood-thinning Drugs Sales Growth Rate (2015-2020) (Units)
Figure 59. China Blood-thinning Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Japan Blood-thinning Drugs Sales Growth Rate (2015-2020) (Units)
Figure 61. Japan Blood-thinning Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. South Korea Blood-thinning Drugs Sales Growth Rate (2015-2020) (Units)
Figure 63. South Korea Blood-thinning Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. India Blood-thinning Drugs Sales Growth Rate (2015-2020) (Units)
Figure 65. India Blood-thinning Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Australia Blood-thinning Drugs Sales Growth Rate (2015-2020) (Units)
Figure 67. Australia Blood-thinning Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Taiwan Blood-thinning Drugs Sales Growth Rate (2015-2020) (Units)
Figure 69. Taiwan Blood-thinning Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Indonesia Blood-thinning Drugs Sales Growth Rate (2015-2020) (Units)
Figure 71. Indonesia Blood-thinning Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Thailand Blood-thinning Drugs Sales Growth Rate (2015-2020) (Units)
Figure 73. Thailand Blood-thinning Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Malaysia Blood-thinning Drugs Sales Growth Rate (2015-2020) (Units)
Figure 75. Malaysia Blood-thinning Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Philippines Blood-thinning Drugs Sales Growth Rate (2015-2020) (Units)
Figure 77. Philippines Blood-thinning Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Vietnam Blood-thinning Drugs Sales Growth Rate (2015-2020) (Units)
Figure 79. Vietnam Blood-thinning Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Asia Pacific Blood-thinning Drugs Market Share by Type in 2019
Figure 81. Asia Pacific Blood-thinning Drugs Market Share by Application in 2019
Figure 82. Latin America Blood-thinning Drugs Sales Growth Rate 2015-2020 (Units)
Figure 83. Latin America Blood-thinning Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 84. Latin America Blood-thinning Drugs Sales Market Share by Country in 2019
Figure 85. Latin America Blood-thinning Drugs Revenue Market Share by Country in 2019
Figure 86. Mexico Blood-thinning Drugs Sales Growth Rate (2015-2020) (Units)
Figure 87. Mexico Blood-thinning Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 88. Brazil Blood-thinning Drugs Sales Growth Rate (2015-2020) (Units)
Figure 89. Brazil Blood-thinning Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Argentina Blood-thinning Drugs Sales Growth Rate (2015-2020) (Units)
Figure 91. Argentina Blood-thinning Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Latin America Blood-thinning Drugs Market Share by Type in 2019
Figure 93. Latin America Blood-thinning Drugs Market Share by Application in 2019
Figure 94. Middle East and Africa Blood-thinning Drugs Sales Growth Rate 2015-2020 (Units)
Figure 95. Middle East and Africa Blood-thinning Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 96. Middle East and Africa Blood-thinning Drugs Sales Market Share by Country in 2019
Figure 97. Middle East and Africa Blood-thinning Drugs Revenue Market Share by Country in 2019
Figure 98. Turkey Blood-thinning Drugs Sales Growth Rate (2015-2020) (Units)
Figure 99. Turkey Blood-thinning Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 100. Saudi Arabia Blood-thinning Drugs Sales Growth Rate (2015-2020) (Units)
Figure 101. Saudi Arabia Blood-thinning Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. U.A.E Blood-thinning Drugs Sales Growth Rate (2015-2020) (Units)
Figure 103. U.A.E Blood-thinning Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Middle East and Africa Blood-thinning Drugs Market Share by Type in 2019
Figure 105. Middle East and Africa Blood-thinning Drugs Market Share by Application in 2019
Figure 106. North America Blood-thinning Drugs Sales Growth Rate Forecast (2021-2026) (Units)
Figure 107. North America Blood-thinning Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 108. Europe Blood-thinning Drugs Sales Growth Rate Forecast (2021-2026) (Units)
Figure 109. Europe Blood-thinning Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 110. Asia Pacific Blood-thinning Drugs Sales Growth Rate Forecast (2021-2026) (Units)
Figure 111. Asia Pacific Blood-thinning Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Latin America Blood-thinning Drugs Sales Growth Rate Forecast (2021-2026) (Units)
Figure 113. Latin America Blood-thinning Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Middle East and Africa Blood-thinning Drugs Sales Growth Rate Forecast (2021-2026) (Units)
Figure 115. Middle East and Africa Blood-thinning Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Porter's Five Forces Analysis
Figure 117. Channels of Distribution
Figure 118. Distributors Profiles
Figure 119. Bottom-up and Top-down Approaches for This Report
Figure 120. Data Triangulation
Figure 121. Key Executives Interviewed
血栓予防治療薬の世界市場（～2026年） Thrombosis is the process of blood clots that form in the artery or veins. In this thrombosis condition, a clot blocks the flow of blood in the affected area and can create serious complications such as myocardial infraction, Strokes atherosclerotic plaque, among others. Deep vein thrombosis is cond…- 抗凝血剤の世界市場（～2026年） Blood thinners are medications taken orally or intravenously (through a vein) to prevent a blood clot. Blood clots can stop the flow of blood to the heart, lungs, or brain. They can cause a heart attack or stroke. There are many Blood thinners in clinical trials, and many are there at different stag…
- 血液検査の世界市場（～2026年） A blood test is the analysis of blood sample performed in a laboratory and the blood is usually taken from the vein in the arm through a needle, or through a finger prick to determine patient’s health status. Blood tests are very often used in health care to understand biochemical and physiological …
- 血液ろ過の世界市場（～2026年） Market Analysis and Insights: Global Blood Filtration Market The global Blood Filtration market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Blood Filtration Scope and Market Size Blood Filtration market is segmented by Ty…
- 菌血症検査の世界市場（～2026年） BSIs occur when any causative organism enters the bloodstream through a wound, injection, or during a surgical procedure. BSI testing is done to detect the cause of these infections. Bloodstream infections are mostly diagnosed by blood culture tests and molecular tests. Commercially available tests …